Smart Biopsy Device Market, 2018-2023: Increasing Adoption of Smart Biopsy Devices Due to the Increasing Prevalence of Cancer is Boosting Growth in the Global Market -

DUBLIN--()--The "Smart Biopsy Device Market" report has been added to's offering.

Report Scope:

The scope of this report is broad and covers potential application sectors across various end-users. The smart biopsy device market is broken down by devices. Revenue forecasts from 2018 to 2023 are given for each application with an estimated value derived from the revenue of manufacturers' total revenues.

The report also includes a discussion of the major players across each regional smart biopsy device market. Further, it explains the major drivers and regional dynamics of the global smart biopsy device market and current trends within the industry.

Report Includes:

  • An overview of the global smart biopsy devices market
  • Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Assessment of current market size, market forecast, and main driving forces for the smart biopsy devices market
  • Coverage of advancements in biopsy procedure and adoption of the minimally invasive biopsy procedure
  • Information on significant products, issues and trends, market influences, regulatory issues and other information affecting the smart biopsy devices market
  • Comprehensive profiles of major vendors in the market

Reasons for Doing This Study

Smart biopsy is used in the diagnosis of cancer and assists in differentiating healthy calluses or cells from tumorous cells. The technique is performed by diagnostic departments and interventional radiologists to recognize diseases in healthcare institutions such as hospitals, diagnostic centers, and medical clinics. Around 100 types of cancers have been identified in organs such as malignant melanoma of the rectum and colon. The numerous forms of biopsies include center needle, skin, excision and incision, vacuum-assisted shave, and fine-needle aspiration. Increasing the adoption of smart biopsy devices due to the increasing prevalence of cancer is boosting growth in the global market.

Key Topics Covered:

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related Reports

Chapter 2 Executive Summary

Chapter 3 Market Overview

  • Introduction
  • Market Potential
  • Market Share
  • Regulatory Framework
  • Establishment Registration and Medical Device Listing
  • Premarket Notification 510(k)
  • Premarket Approval
  • Investigational Device Exemption (IDE)
  • Quality System Regulation
  • Labeling Requirements
  • Medical Device Reporting (MDR)
  • Growth Drivers and Trends
  • Increasing Prevalence of Cancer
  • Increasing Number of Cancer Research Studies
  • Advancement of Biopsy Procedures and Adoption of Minimally Invasive Biopsy Procedures

Chapter 4 Smart Biopsy Device Applications

  • Overview
  • Cancer Applications
  • Breast Cancer
  • Skin Cancer
  • Prostate Cancer
  • Liver Cancer
  • Other Cancers

Chapter 5 Regional Markets for Smart Biopsy Devices

  • Overview
  • Regional Markets
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Chapter 6 Company Profiles

  • Argon Medical Devices
  • B. Braun Melsungen AG
  • Becton, Dickinson, and Co.
  • Boston Scientific Corp.
  • Canon Medical Systems
  • Dune Medical Devices
  • Hologic Inc.
  • Innomedicus Ltd.
  • Planmed OY
  • RLS Interventional (Inrad)

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900